BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND PAX8, ENSG00000125618, 7849 AND Prognosis
48 results:

  • 1. Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules.
    Zhang M; Hu X; Liu L; Wang Y; Jiang J; Li H; Fei W; Zhong T; Jiang Z
    Medicine (Baltimore); 2024 Jan; 103(4):e35960. PubMed ID: 38277563
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Clinicopathological features of thyroid-like low-grade nasopharyngeal papillary adenocarcinoma].
    Zhu M; Li J; Zheng WH; Wu MJ
    Zhonghua Bing Li Xue Za Zhi; 2023 Aug; 52(8):820-826. PubMed ID: 37527987
    [No Abstract]    [Full Text] [Related]  

  • 3. Papillary thyroid carcinoma with aggressive fused follicular and solid growth pattern: A unique histological subtype with high-grade malignancy?
    Murata SI; Matsuzaki I; Kishimoto M; Katsuki N; Onishi T; Hirokawa M; Kojima F
    Pathol Int; 2023 May; 73(5):207-211. PubMed ID: 37042564
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Immunohistochemical characteristics of thyroid-like low-grade nasopharyngeal papillary adenocarcinoma: A case report and review.
    Guo H; Zhang Z; Huang C; Qiu J; Qu X
    Medicine (Baltimore); 2023 Jan; 102(4):e32655. PubMed ID: 36705380
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Papillary Thyroid Carcinoma With Squamous Dedifferentiation: A Potential Diagnostic Pitfall.
    Ijaz K; Yin F
    Anticancer Res; 2023 Jan; 43(1):255-258. PubMed ID: 36585182
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinicopathological and immunohistochemical behavior of ductal carcinoma of the salivary and lacrimal gland in a Mexican Mestizo population.
    Luna-Ortiz K; Dominguez-Malagon H; Corredor-Alonso GE; Reynoso-Noveron N; Herrera-Ponzanelli C; Luna-Peteuil Z; Zacarias-Ramon LC
    Eur Arch Otorhinolaryngol; 2022 Jan; 279(1):327-333. PubMed ID: 33763743
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Sinonasal renal cell-like adenocarcinoma: a clinicopathological analysis of five cases].
    Yuan CC; Zhai CW; Wang SY
    Zhonghua Bing Li Xue Za Zhi; 2020 Nov; 49(11):1147-1151. PubMed ID: 33152820
    [No Abstract]    [Full Text] [Related]  

  • 8. Identification of an immune-related key gene, PPARGC1A, in the development of anaplastic thyroid carcinoma: in-silico study and in-vitro evaluation.
    Huang Y; Ling J; Chang A; Ye H; Zhao H; Zhuo X
    Minerva Endocrinol (Torino); 2022 Jun; 47(2):150-159. PubMed ID: 32720497
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study.
    Bardet S; Goardon N; Lequesne J; Vaur D; Ciappuccini R; Leconte A; Monpeyssen H; Saguet-Rysanek V; Clarisse B; Lasne-Cardon A; Ménégaux F; Leenhardt L; Buffet C
    Endocrine; 2021 Feb; 71(2):407-417. PubMed ID: 32638211
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Signet ring cell variant of follicular thyroid carcinoma: Report of two cases with focus on morphological, expressional and genetic characteristics.
    Hysek M; Jatta K; Stenman A; Darai-Ramqvist E; Zedenius J; Höög A; Juhlin CC
    Diagn Pathol; 2019 Nov; 14(1):127. PubMed ID: 31699114
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Emerging Roles of GLI-Similar Krüppel-like Zinc Finger Transcription Factors in Leukemia and Other cancers.
    Jetten AM
    Trends Cancer; 2019 Sep; 5(9):547-557. PubMed ID: 31474360
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Molecular Variants and Their Risks for Malignancy in Cytologically Indeterminate Thyroid Nodules.
    Goldner WS; Angell TE; McAdoo SL; Babiarz J; Sadow PM; Nabhan FA; Nasr C; Kloos RT
    Thyroid; 2019 Nov; 29(11):1594-1605. PubMed ID: 31469053
    [No Abstract]    [Full Text] [Related]  

  • 13. Coding Molecular Determinants of Thyroid cancer Development and Progression.
    Valvo V; Nucera C
    Endocrinol Metab Clin North Am; 2019 Mar; 48(1):37-59. PubMed ID: 30717910
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Metastasis to Stomach in a Patient with Anaplastic Thyroid Carcinoma: A Clinical Challenge.
    Fuladi R; Nagarkar R; Roy S
    Am J Case Rep; 2019 Feb; 20():134-138. PubMed ID: 30705249
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Mammary Analogue Secretory Carcinoma of the Thyroid Mimicking Locally Advanced Papillary Thyroid Carcinoma: A Rare Case Report.
    Liao H; Khan A; Miron PM; Cornejo KM
    Int J Surg Pathol; 2018 Aug; 26(5):459-463. PubMed ID: 29228842
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Molecular pathology and thyroid FNA.
    Poller DN; Glaysher S
    Cytopathology; 2017 Dec; 28(6):475-481. PubMed ID: 29165888
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Changes in the clinicopathological characteristics and genetic alterations of follicular thyroid cancer.
    Song YS; Lim JA; Min HS; Kim MJ; Choi HS; Cho SW; Moon JH; Yi KH; Park DJ; Cho BY; Park YJ
    Eur J Endocrinol; 2017 Dec; 177(6):465-473. PubMed ID: 28864536
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Sinonasal renal cell-like adenocarcinoma, a unique variant of primary clear cell carcinoma of the head and neck: The first reported case in Korea.
    Kim NI; Yang JI; Kim SS; Lee JS; Lim SC; Jung S; Lee JH; Moon KS; Lee KH
    Medicine (Baltimore); 2017 Aug; 96(31):e7711. PubMed ID: 28767609
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Chromophobe renal cell carcinoma-like thyroid carcinoma: A novel clinicopathologic entity possibly associated with tuberous sclerosis complex.
    Hirokawa M; Miyauchi A; Kihara M; Kudo T; Hashimoto Y; Suzuki S; Daa T; Vuong HG; Mitsutake N
    Endocr J; 2017 Sep; 64(9):843-850. PubMed ID: 28680002
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive Histotypes.
    Penna GC; Vaisman F; Vaisman M; Sobrinho-Simões M; Soares P
    Cytogenet Genome Res; 2016; 150(3-4):194-207. PubMed ID: 28231576
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.